A replication-deficient adenovirus encoding fusion proteins comprised of calreticulin, known to enhance MHC-I expression on cell surface, and E7 antigen (CRT/E7) has been shown to generate a potent and protective cellular response to E7, in an established tumour model in mice [136]. This evidence concerns the gene CALR and neoplasm.